首页> 外文期刊>Disease markers >Inflammation, adenoma and cancer: Objective classification of colon biopsy specimens with gene expression signature
【24h】

Inflammation, adenoma and cancer: Objective classification of colon biopsy specimens with gene expression signature

机译:炎症,腺瘤和癌症:具有基因表达签名的结肠活检标本的客观分类

获取原文
获取原文并翻译 | 示例
       

摘要

Gene expression analysis of colon biopsies using high-density oligonucleotide microarrays can contribute to the understanding of local pathophysiological alterations and to functional classification of adenoma (15 samples), colorectal carcinomas (CRC) (15) and inflammatory bowel diseases (IBD) (14). Total RNA was extracted, amplified and biotinylated from frozen colonic biopsies. Genome-wide gene expression profile was evaluated by HGU133plus2 microarrays and verified by RT-PCR. We applied two independent methods for data normalization and used PAM for feature selection. Leave one-out stepwise discriminant analysis was performed. Top validated genes included collagenTValphal, lipocalin-2, calumenin, aquaporin-8 genes in CRC; CD44, met proto-oncogene, chemokine ligand-12, ADAM-like decysin-1 and ATP-binding casette-A8 genes in adenoma; and lipocalin-2, ubiquitin D and IFITM2 genes in IBD. Best differentiating markers between Ulcerative colitis and Crohn's disease were cyclin-G2; tripartite motif-containing-31; TNFR shedding aminopeptidase regulator-1 and AMICA. The discriminant analysis was able to classify the samples in overall 96.2% using 7 discriminatory genes (indoleamine-pyrrole-2,3-dioxygenase, ectodermal-neural cortex, TTMP3, fucosyltransferase-8, collectin sub-family member 12, carboxypeptidase D, and transglutaminase-2). Using routine biopsy samples we successfully performed whole genomic microarray analysis to identify discriminative signatures. Our results provide further insight into the pathophysiological background of colonic diseases. The results set up data warehouse which can be mined further.
机译:使用高密度寡核苷酸微阵列的结肠活组织检查的基因表达分析可以有助于了解局部病理生理改变和腺瘤(15个样品)的功能分类,结直肠癌(CRC)(15)和炎性肠病(IBD)(14) 。从冷冻结肠活组织检查中提取,扩增和生物素化总RNA。通过HGU133PLUS2微阵列评估基因组基因表达谱并通过RT-PCR验证。我们应用了两个独立的数据归一化方法,并使用PAM进行功能选择。留出逐步判断判别分析。顶部验证的基因包括CollagentValphal,Lipocalin-2,CrC中的Aquaporin-8基因; CD44,在腺瘤中遇到原甲基,趋化因子配体-1和ADAM样滤片蛋白-1和ATP结合患者-A8基因;和脂素-2,IBD中的泛素D和IFITM2基因。溃疡性结肠炎和克罗恩病之间的最佳分化标志物是细胞周期蛋白-G2;含三方主题-31; TNFR脱落氨基肽酶调节剂-1和Amica。判别分析能够使用7个鉴别基因(吲哚胺 - 吡咯-2,3-二恶氧酶,难素 - 神经皮层,TTMP3,岩藻糖基转移酶-8,Collecin Sub家族构件12,羧肽酶D和转谷氨酰胺酶-2)。使用常规活检样本,我们成功地进行了全基因组微阵列分析以确定鉴别性签名。我们的结果提供了进一步了解结肠病病理生理学背景。结果设置了数据仓库,可以进一步开采。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号